Skip to main content

Peer Review reports

From: The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

Original Submission
8 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
14 Jan 2022 Reviewed Reviewer Report
2 Feb 2022 Reviewed Reviewer Report - Najoua Lalaoui
18 Feb 2022 Author responded Author comments - Dirk Spitzer
Resubmission - Version 4
18 Feb 2022 Submitted Manuscript version 4
28 Feb 2022 Reviewed Reviewer Report - Najoua Lalaoui
1 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
1 Mar 2022 Editorially accepted
12 Mar 2022 Article published 10.1186/s12885-022-09367-w

You can find further information about peer review here.

Back to article page